PL345216A1 - Methods and transdermal compositions for pain relief - Google Patents

Methods and transdermal compositions for pain relief

Info

Publication number
PL345216A1
PL345216A1 PL99345216A PL34521699A PL345216A1 PL 345216 A1 PL345216 A1 PL 345216A1 PL 99345216 A PL99345216 A PL 99345216A PL 34521699 A PL34521699 A PL 34521699A PL 345216 A1 PL345216 A1 PL 345216A1
Authority
PL
Poland
Prior art keywords
methods
pain relief
transdermal compositions
transdermal
compositions
Prior art date
Application number
PL99345216A
Other languages
English (en)
Inventor
Robert W Murdock
Donald C Williams
Original Assignee
Pharmaceuticals Applic Asociat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/106,684 external-priority patent/US6290986B1/en
Application filed by Pharmaceuticals Applic Asociat filed Critical Pharmaceuticals Applic Asociat
Publication of PL345216A1 publication Critical patent/PL345216A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL99345216A 1998-06-29 1999-06-29 Methods and transdermal compositions for pain relief PL345216A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,684 US6290986B1 (en) 1996-10-24 1998-06-29 Method and composition for transdermal administration of pharmacologic agents
US12290399P 1999-03-05 1999-03-05

Publications (1)

Publication Number Publication Date
PL345216A1 true PL345216A1 (en) 2001-12-03

Family

ID=26803907

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99345216A PL345216A1 (en) 1998-06-29 1999-06-29 Methods and transdermal compositions for pain relief

Country Status (18)

Country Link
EP (1) EP1093348A4 (xx)
JP (1) JP2002519310A (xx)
KR (1) KR20010078754A (xx)
CN (1) CN1331576A (xx)
AU (1) AU4841599A (xx)
BG (1) BG105175A (xx)
BR (1) BR9912508A (xx)
CA (1) CA2335837A1 (xx)
HR (1) HRP20000905A2 (xx)
HU (1) HUP0102728A3 (xx)
ID (1) ID28213A (xx)
IL (1) IL140420A0 (xx)
MX (1) MXPA00012767A (xx)
NO (1) NO20006604L (xx)
PL (1) PL345216A1 (xx)
SK (1) SK20012000A3 (xx)
TR (1) TR200003801T2 (xx)
WO (1) WO2000000120A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
BR9809288A (pt) 1997-04-22 2001-08-07 Cocensys Inc Semicarbazonas e tiosemicarbazonas substituìdas carbocìclicas e heterocìclicas e utilização das mesmas
EP1500395B1 (en) * 1999-07-01 2006-03-08 Pharmacia & Upjohn Company LLC Reboxetine for treating fibromyalgia and other somatoform disorders
PT1632234E (pt) 1999-07-01 2007-07-09 Pharmacia & Upjohn Co Llc (s,s)-reboxetina para o tratamento da síndrome de fadiga crónica
WO2001041732A1 (en) * 1999-12-06 2001-06-14 Gore Stanley L Compositions and methods for intranasal delivery of active agents to the brain
IN191512B (xx) * 2000-01-21 2003-12-06 Panacea Biotech
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
JP4865330B2 (ja) 2002-12-13 2012-02-01 デュレクト コーポレーション 経口ドラッグデリバリーシステム
JP2005154368A (ja) * 2003-11-27 2005-06-16 Teikoku Seiyaku Co Ltd ジソピラミド含有神経因性疼痛の鎮痛剤
JP4807721B2 (ja) * 2004-01-29 2011-11-02 株式会社 メドレックス 消炎鎮痛外用剤
AU2005287175B2 (en) 2004-09-17 2011-12-01 Durect Corporation Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
JP2007308403A (ja) * 2006-05-17 2007-11-29 Kenji Yoshida 皮膚外用剤
KR100880748B1 (ko) * 2006-08-29 2009-02-02 정헌택 디메톡시커큐민을 함유하는 혈관재협착 방지용 조성물
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
JP5826742B2 (ja) * 2009-05-07 2015-12-02 ドンコック ファーマシューティカル カンパニー リミテッド 神経損傷及び神経疾患の予防または治療用薬学組成物
US8491927B2 (en) * 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
JP2017505349A (ja) * 2014-02-11 2017-02-16 ドクター レディズ ラボラトリーズ リミテッド セレコキシブの非経口組成物
CA3117842A1 (en) 2018-10-26 2020-04-30 Viramal Limited Mucoadhesive gel composition
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
FR3108841B1 (fr) * 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395420A (en) * 1981-12-09 1983-07-26 Bernstein Joel E Method and composition for treating pruritis
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain

Also Published As

Publication number Publication date
AU4841599A (en) 2000-01-17
WO2000000120A9 (en) 2000-03-30
TR200003801T2 (tr) 2001-06-21
CN1331576A (zh) 2002-01-16
ID28213A (id) 2001-05-10
BR9912508A (pt) 2001-05-02
MXPA00012767A (es) 2002-08-09
NO20006604D0 (no) 2000-12-22
BG105175A (bg) 2001-11-30
HUP0102728A3 (en) 2002-12-28
CA2335837A1 (en) 2000-01-06
HRP20000905A2 (en) 2001-08-31
IL140420A0 (en) 2002-02-10
WO2000000120A1 (en) 2000-01-06
HUP0102728A2 (hu) 2002-03-28
JP2002519310A (ja) 2002-07-02
EP1093348A4 (en) 2003-07-16
EP1093348A1 (en) 2001-04-25
KR20010078754A (ko) 2001-08-21
SK20012000A3 (sk) 2001-08-06
NO20006604L (no) 2001-02-28

Similar Documents

Publication Publication Date Title
IL140420A0 (en) Methods and transdermal compositions for pain relief
AU2002234192A8 (en) Methods and transdermal compositions for pain relief
AU2024500A (en) Intraoral electromuscular stimulation device and method
AU6872498A (en) Method and composition for skin treatment
HUP0103621A3 (en) Fentanyl composition for the treatment of acute pain
EP1065978A4 (en) IMPLANTABLE THERAPEUTIC DEVICE AND METHOD THEREOF
AU5439996A (en) Compositions and methods for treating pain
HK1031174A1 (en) Compositions and methods for treating diabetes
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
AU3877900A (en) Compositions and methods for preventing and treating sexual dysfunctions
AU2542097A (en) Oligonucleotide treatments and compositions for human melanoma
IL116895A (en) Transdermal patch comprising xanomeline
AU3784999A (en) Methods for treatment of pain
AU6056500A (en) Process and composition for temporarily suppressing pain
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
PL329217A1 (en) Pain relieving method
AU3204899A (en) Hair treatment composition and method
EP1007041A4 (en) COMPOSITION FOR TREATING PAIN
AU2420101A (en) Method and composition for the treatment of pain
AU5169200A (en) Methods and compositions for treating breakthrough pain
AU7247898A (en) Composition for treating pain
IL150202A0 (en) Method and composition for the treatment of pain
EP1112250A4 (en) THERAPEUTIC COMPOUNDS AND RELATED METHODS
AU5097099A (en) Methods and compositions for cancer treatment
AU5768300A (en) Pain relief composition and method of relieving pain